Cargando…
Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders
BACKGROUND: Genome wide association studies have identified microtubule associated protein tau (MAPT) H1 haplotype single nucleotide polymorphisms (SNPs) as leading common risk variants for Parkinson’s disease, progressive supranuclear palsy and corticobasal degeneration. The MAPT risk variants fall...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663040/ https://www.ncbi.nlm.nih.gov/pubmed/29084565 http://dx.doi.org/10.1186/s13024-017-0224-6 |
_version_ | 1783274750881038336 |
---|---|
author | Lai, Mang Ching Bechy, Anne-Laure Denk, Franziska Collins, Emma Gavriliouk, Maria Zaugg, Judith B. Ryan, Brent J. Wade-Martins, Richard Caffrey, Tara M. |
author_facet | Lai, Mang Ching Bechy, Anne-Laure Denk, Franziska Collins, Emma Gavriliouk, Maria Zaugg, Judith B. Ryan, Brent J. Wade-Martins, Richard Caffrey, Tara M. |
author_sort | Lai, Mang Ching |
collection | PubMed |
description | BACKGROUND: Genome wide association studies have identified microtubule associated protein tau (MAPT) H1 haplotype single nucleotide polymorphisms (SNPs) as leading common risk variants for Parkinson’s disease, progressive supranuclear palsy and corticobasal degeneration. The MAPT risk variants fall within a large 1.8 Mb region of high linkage disequilibrium, making it difficult to discern the functionally important risk variants. Here, we leverage the strong haplotype-specific expression of MAPT exon 3 to investigate the functionality of SNPs that fall within this H1 haplotype region of linkage disequilibrium. METHODS: In this study, we dissect the molecular mechanisms by which haplotype-specific SNPs confer allele-specific effects on the alternative splicing of MAPT exon 3. Firstly, we use haplotype-hybrid whole-locus genomic MAPT vectors studies to identify functional SNPs. Next, we characterise the RNA-protein interactions at two loci by mass spectrometry. Lastly, we knockdown candidate splice factors to determine their effect on MAPT exon 3 using a novel allele-specific qPCR assay. RESULTS: Using whole-locus genomic DNA expression vectors to express MAPT haplotype variants, we demonstrate that rs17651213 regulates exon 3 inclusion in a haplotype-specific manner. We further investigated the functionality of this region using RNA-electrophoretic mobility shift assays to show differential RNA-protein complex formation at the H1 and H2 sequence variants of SNP rs17651213 and rs1800547 and subsequently identified candidate trans-acting splicing factors interacting with these functional SNPs sequences by RNA-protein pull-down experiment and mass spectrometry. Finally, gene knockdown of candidate splice factors identified by mass spectrometry demonstrate a role for hnRNP F and hnRNP Q in the haplotype-specific regulation of exon 3 inclusion. CONCLUSIONS: We identified common splice factors hnRNP F and hnRNP Q regulating the haplotype-specific splicing of MAPT exon 3 through intronic variants rs1800547 and rs17651213. This work demonstrates an integrated approach to characterise the functionality of risk variants in large regions of linkage disequilibrium. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-017-0224-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5663040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56630402017-11-01 Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders Lai, Mang Ching Bechy, Anne-Laure Denk, Franziska Collins, Emma Gavriliouk, Maria Zaugg, Judith B. Ryan, Brent J. Wade-Martins, Richard Caffrey, Tara M. Mol Neurodegener Research Article BACKGROUND: Genome wide association studies have identified microtubule associated protein tau (MAPT) H1 haplotype single nucleotide polymorphisms (SNPs) as leading common risk variants for Parkinson’s disease, progressive supranuclear palsy and corticobasal degeneration. The MAPT risk variants fall within a large 1.8 Mb region of high linkage disequilibrium, making it difficult to discern the functionally important risk variants. Here, we leverage the strong haplotype-specific expression of MAPT exon 3 to investigate the functionality of SNPs that fall within this H1 haplotype region of linkage disequilibrium. METHODS: In this study, we dissect the molecular mechanisms by which haplotype-specific SNPs confer allele-specific effects on the alternative splicing of MAPT exon 3. Firstly, we use haplotype-hybrid whole-locus genomic MAPT vectors studies to identify functional SNPs. Next, we characterise the RNA-protein interactions at two loci by mass spectrometry. Lastly, we knockdown candidate splice factors to determine their effect on MAPT exon 3 using a novel allele-specific qPCR assay. RESULTS: Using whole-locus genomic DNA expression vectors to express MAPT haplotype variants, we demonstrate that rs17651213 regulates exon 3 inclusion in a haplotype-specific manner. We further investigated the functionality of this region using RNA-electrophoretic mobility shift assays to show differential RNA-protein complex formation at the H1 and H2 sequence variants of SNP rs17651213 and rs1800547 and subsequently identified candidate trans-acting splicing factors interacting with these functional SNPs sequences by RNA-protein pull-down experiment and mass spectrometry. Finally, gene knockdown of candidate splice factors identified by mass spectrometry demonstrate a role for hnRNP F and hnRNP Q in the haplotype-specific regulation of exon 3 inclusion. CONCLUSIONS: We identified common splice factors hnRNP F and hnRNP Q regulating the haplotype-specific splicing of MAPT exon 3 through intronic variants rs1800547 and rs17651213. This work demonstrates an integrated approach to characterise the functionality of risk variants in large regions of linkage disequilibrium. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13024-017-0224-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-30 /pmc/articles/PMC5663040/ /pubmed/29084565 http://dx.doi.org/10.1186/s13024-017-0224-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lai, Mang Ching Bechy, Anne-Laure Denk, Franziska Collins, Emma Gavriliouk, Maria Zaugg, Judith B. Ryan, Brent J. Wade-Martins, Richard Caffrey, Tara M. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders |
title | Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders |
title_full | Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders |
title_fullStr | Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders |
title_full_unstemmed | Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders |
title_short | Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders |
title_sort | haplotype-specific mapt exon 3 expression regulated by common intronic polymorphisms associated with parkinsonian disorders |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663040/ https://www.ncbi.nlm.nih.gov/pubmed/29084565 http://dx.doi.org/10.1186/s13024-017-0224-6 |
work_keys_str_mv | AT laimangching haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT bechyannelaure haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT denkfranziska haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT collinsemma haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT gavrilioukmaria haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT zauggjudithb haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT ryanbrentj haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT wademartinsrichard haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders AT caffreytaram haplotypespecificmaptexon3expressionregulatedbycommonintronicpolymorphismsassociatedwithparkinsoniandisorders |